美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
63629-8447-1	63629-8447	HUMAN PRESCRIPTION DRUG	Repaglinide	REPAGLINIDE	TABLET	ORAL	20130809	N/A	ANDA	ANDA201189	Bryant Ranch Prepack	REPAGLINIDE	.5 mg/1	100 TABLET in 1 BOTTLE (63629-8447-1)
63629-8448-1	63629-8448	HUMAN PRESCRIPTION DRUG	Repaglinide	REPAGLINIDE	TABLET	ORAL	20140122	N/A	ANDA	ANDA201189	Bryant Ranch Prepack	REPAGLINIDE	1 mg/1	100 TABLET in 1 BOTTLE (63629-8448-1)
63629-8449-1	63629-8449	HUMAN PRESCRIPTION DRUG	Repaglinide	REPAGLINIDE	TABLET	ORAL	20140122	N/A	ANDA	ANDA201189	Bryant Ranch Prepack	REPAGLINIDE	2 mg/1	100 TABLET in 1 BOTTLE (63629-8449-1)
72162-1112-1	72162-1112	HUMAN PRESCRIPTION DRUG	Repaglinide	REPAGLINIDE	TABLET	ORAL	20230330	N/A	ANDA	ANDA201189	Bryant Ranch Prepack	REPAGLINIDE	.5 mg/1	100 TABLET in 1 BOTTLE (72162-1112-1)
72162-1113-1	72162-1113	HUMAN PRESCRIPTION DRUG	Repaglinide	REPAGLINIDE	TABLET	ORAL	20230330	20250131	ANDA	ANDA201189	Bryant Ranch Prepack	REPAGLINIDE	1 mg/1	100 TABLET in 1 BOTTLE (72162-1113-1)
72162-1114-1	72162-1114	HUMAN PRESCRIPTION DRUG	Repaglinide	REPAGLINIDE	TABLET	ORAL	20230330	20240531	ANDA	ANDA201189	Bryant Ranch Prepack	REPAGLINIDE	2 mg/1	100 TABLET in 1 BOTTLE (72162-1114-1)
63629-9194-1	63629-9194	HUMAN PRESCRIPTION DRUG	Repaglinide	REPAGLINIDE	TABLET	ORAL	20220803	20240531	ANDA	ANDA201189	Bryant Ranch Prepack	REPAGLINIDE	2 mg/1	100 TABLET in 1 BOTTLE (63629-9194-1)
0574-0240-01	0574-0240	HUMAN PRESCRIPTION DRUG	Repaglinide	REPAGLINIDE	TABLET	ORAL	20130809	N/A	ANDA	ANDA201189	Padagis US LLC	REPAGLINIDE	.5 mg/1	100 TABLET in 1 BOTTLE (0574-0240-01)
0574-0241-01	0574-0241	HUMAN PRESCRIPTION DRUG	Repaglinide	REPAGLINIDE	TABLET	ORAL	20140122	20250131	ANDA	ANDA201189	Padagis US LLC	REPAGLINIDE	1 mg/1	100 TABLET in 1 BOTTLE (0574-0241-01)
0574-0242-01	0574-0242	HUMAN PRESCRIPTION DRUG	Repaglinide	REPAGLINIDE	TABLET	ORAL	20140122	20240531	ANDA	ANDA201189	Padagis US LLC	REPAGLINIDE	2 mg/1	100 TABLET in 1 BOTTLE (0574-0242-01)